In vitro selection and efficacy of topical skin protectants against the nerve agent VX

Toxicology in Vitro

Volumn 23, Issue 3, 2009, Pages 539-545

  Millerioux, J ^a,b   Cruz, C ^b   Bazire, A ^b   Lallement, G ^b   Lefeuvre, L ^a   Josse, D ^b  

^a Laboratoires Dermatologiques d'Uriage   (France)

^b CENTRE DE RECHERCHES   (France)

Author keywords

Barrier cream; Chemical warfare agents; Human skin; Hydrogel; In vitro; Nerve agent; Pig skin; Silicone membrane; Topical skin protectant; VX

Indexed keywords

METHYLPHOSPHONOTHIOIC ACID S (2 DIISOPROPYLAMINOETHYL) O ETHYL ESTER; PERFLUORO COMPOUND; POLYMER; SILICONE; SKIN PROTECTIVE AGENT;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG FORMULATION; EMULSION; HUMAN; HUMAN TISSUE; HYDROGEL; IN VITRO SELECTION; MEMBRANE PERMEABILITY; NONHUMAN; SKIN MANIFESTATION; SKIN PROTECTION; SKIN TOXICITY;

ADMINISTRATION, TOPICAL; ANIMALS; CHEMICAL WARFARE AGENTS; HUMANS; HYDROGELS; MEMBRANES, ARTIFICIAL; NEUROPROTECTIVE AGENTS; ORGANOTHIOPHOSPHORUS COMPOUNDS; REPRODUCIBILITY OF RESULTS; SILICONES; SKIN; SWINE;

SUIDAE;

EID: 60849099611     PISSN: 08872333     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tiv.2009.01.008     Document Type: Article

References (34)

1. Bhaskar K., Krishna Mohan C., Lingam M., Jagan Mohan S., Venkateswarlu V., Madhusudan Rao Y., Bhaskar K., Anbu J., and Ravichandran V. Development of SLN and NLC enriched hydrogels for transdermal delivery of nitrendipine: in vitro and in vivo characteristics. Drug Development and Industrial Pharmacy 29 (2008) 1-16
2. Braue Jr. E.H. Development of a reactive topical skin protectant. Journal of Applied Toxicology 19 (1999) S47-S53
3. Bronaugh R.L., and Stewart R.F. Methods for in vitro percutaneous absorption studies IV: the flow-through diffusion cell. Journal of Pharmaceutical Sciences 74 1 (1985) 64-67
4. Burke S.A., Ritter-Jones M., Lee B.P., and Messersmith P.B. Thermal gelation and tissue adhesion of biomimetic hydrogels. Biomedical Materials 2 4 (2007) 203-210
5. Chilcott R.P., Jenner J., Hotchkiss S.A.M., and Rice P. Evaluation of barrier creams against sulphur mustard: (I) in vitro studies using human skin. Skin Pharmacology and Applied Skin Physiology 15 (2002) 225-235
6. Chilcott R.P., Dalton C.H., Hill I., Davison C.M., Blohm K.L., Clarkson E.D., and Hamilton M.G. Evaluation of a barrier cream against the chemical warfare agent VX using the domestic white pig. Basic and Clinical Pharmacology and Toxicology 97 (2005) 35-38
7. Chilcott R.P., Dalton C.H., Ashley Z., Allen C.E., Bradley S.T., Maidment M.P., Jenner J., Brown R.F.R., Gwyther R.J., and Rice P. Evaluation of barrier creams against sulphur mustard: (II) in vivo and in vitro studies using the domestic white pig. Cutaneous and Ocular Toxicology 26 3 (2007) 235-247
8. Clément P., Laugel C., and Marty J.P. Influence of three synthetic membranes on the release of caffeine from concentrated W/O emulsions. Journal of Controlled Release 66 2-3 (2000) 243-254
9. Dalton C.H., Hattersley I.J., Rutter S.J., and Chilcott R.P. Absorption of the nerve agent VX (O-ethyl-S-[2(di-isopropylamino)ethyl] methyl phosphonothioate) through pig, human and guinea pig skin in vitro. Toxicology in Vitro 20 (2006) 1532-1536
10. Dick I.P., and Scott R.C. Pig ear skin as an in vitro model for human skin permeability. Journal of Pharmacy and Pharmacology 44 (1992) 640-645
11. Dickson E.F. Estimates of percutaneous toxicity of sulfur mustard vapor suitable for use in protective equipment standards. Journal of Toxicology and Environmental Health. Part A 71 20 (2008) 1382-1391
12. Draelos Z.D. Hydrogel barrier/repair creams and contact dermatitis. American Journal of Contact Dermatitis 11 4 (2000) 222-225
13. Elsner P., Wigger-Alberti W., and Pantini G. Perfluoropolyethers in the prevention of irritant contact dermatitis. Dermatology 197 2 (1998) 141-145
14. Frum Y., Eccleston G.M., and Meidan V.M. In-vitro permeation of drug into porcine hair follicles: is it equivalent to permeation into human hair follicles?. The Journal of Pharmacy and Pharmacology 60 2 (2008) 145-151
15. Jacobi U., Kaiser M., Toll R., Mangelsdorf S., Audring H., Otberg N., Sterry W., and Lademann J. Porcine ear skin: an in vitro model for human skin. Skin Research and Technology 13 (2007) 19-24
16. Kadar T., Fishbine E., Meshulam J., Sahar R., Amir A., and Barness I. A topical skin protectant against chemical warfare agents. The Israel Medical Association Journal 5 10 (2003) 717-719
17. Leveque N., Raghavan S.L., Lane M.E., and Hadgraft J. Use of a molecular form technique for the penetration of supersaturated solutions of salicylic acid across silicone membranes and human skin in vitro. International Journal of Pharmaceutics 318 1-2 (2006) 49-54
18. Loke W.K., Karlsson B., Waara L., Göransson Nyberg A., and Cassel G.E. Enzyme-based microassay for accurate determination of soman in blood samples. Analytical Biochemistry 257 (1998) 12-19
19. Millerioux J., Cruz C., Bazire A., Polly V., Lallement G., Lefeuvre L., and Josse D. Evaluation of in vitro tests to assess the efficacy of formulations as topical skin protectants against organophosphorus compounds. Toxicology in Vitro 23 (2009) 127-133
20. Milutinović R., Vuleta G., Milić J., and Stajković N. Assessment of efficiency of repellent formulations with N,N-diethyl-m-toluamide in laboratory conditions. International Journal of Cosmetic Science 21 1 (1999) 7-14
21. OECD Environment Health and Safety Publications, Series on Testing and Assessment, No. 28, Guidance Document for the Conduct of Skin Absorption Studies, March 2004, OECD, Paris.
22. Olson C.T., Feder P.I., Hobson D.W., Kiser R.C., and Joiner R.L. Evaluation of compounds as barriers to dermal penetration organophosphates using acetylcholinesterase inhibition. Toxicology Letters 55 (1991) 325-334
23. Pellett M.A., Castellano S., Hadgraft J., and Davis A.F. The penetration of supersaturated solutions of piroxicam across silicone membranes and human skin in vitro. Journal of Controlled Release 46 (1997) 205-214
24. Reifenrath W.G., Lee B., Wilson D.R., and Spencer T.S. A comparison of in vitro skin-penetration cells. Journal of Pharmaceutical Sciences 83 9 (1994) 1229-1233
25. Schliemann S., and Elsner P. Skin Protection. Current Problems in Dermatology vol. 34 (2007), Basel Karger p. 182
26. Schliemann-Willers S., Wigger-Alberti W., and Elsner P. Efficacy of a new class of perfluoropolyethers in the prevention of irritant contact dermatitis. Acta Dermato-Venereologica 81 6 (2001) 392-394
27. Schmook F.P., Meingassner J.G., and Billich A. Comparison of human skin or epidermis models with human and animal skin in in-vitro percutaneous absorption. International Journal of Pharmaceutics 215 1-2 (2001) 51-56
28. Vallet V., Cruz C., Josse D., Bazire A., Lallement G., and Boudry I. In vitro percutaneous penetration of organophosphorus compounds using full-thickness and split-thickness pig and human skin. Toxicology in Vitro 21 (2007) 1182-1190
29. Vertuani S., Ziosi P., Solaroli N., Buzzoni V., Carli M., Lucchi E., Valgimigli L., Baratto G., and Manfredini S. Determination of antioxidant efficacy of cosmetic formulations by non-invasive measurements. Skin Research and Technology 9 (2003) 245-253
30. Wang T., Kasichayanula S., and Gu X. In vitro permeation of repellent DEET and sunscreen oxybenzone across three artificial membranes. International Journal of Pharmaceutics 310 (2006) 110-117
31. Yang Y.-C. Chemical detoxification of nerve agent VX. Accounts of Chemical Research 32 (1999) 109-115
32. Zhai H., and Maibach H.I. Test for skin protection: barrier effect. In: Barel A.O., Paye M., and Maibach H.I. (Eds). Handbook of Cosmetic Science and Technology (2001), Marcel Dekker, Inc., New York, USA 823-828
33. Zhai H., and Maibach H.I. Barrier creams-skin protectants: can you protect skin?. Journal of Cosmetic Dermatology 1 (2002) 20-23
34. zur Mühlen A., Klotz A., Allef P., Weimans S., Veeger M., Thörner B., and Eichler J.O. Using skin models to assess the effects of a pre-work cream. Methodological aspects and perspective of the industry. Current Problems in Dermatology 34 (2007) 19-32